Tommaso Dragani

CEO, Aspidia

Tommaso A. Dragani, MPharm, University of Bologna (1977); MSc in Epidemiology and Statistics, University of Milan (2007); Visiting Scientist at Columbia University (USA) and the National Cancer Center (Japan). Founder and CEO of ASPIDIA, a biotech startup developing advanced PFAS remediation and enzyme-based bioremediation technologies. Former Director of a cancer research unit at the National Cancer Institute of Milan, author of 196 peer-reviewed papers (H-index 47).